In-Vitro Diagnostics Market Report 2016-2021 Now Available at MarketD April.2017 | Page 2
Global In-Vitro Diagnostics Market
According to the report "In-Vitro Diagnostics Market", published by Market Data Forecast,
the global market is projected to reach USD 78.07 Billion by 2021, at a CAGR of 5.6% from
2016 to 2021.
In-Vitro diagnostics involve tests that can help in detecting diseases, conditions or infections.
A number of these tests are performed in laboratory or healthcare settings while other tests
are for consumers to use at home. In-Vitro diagnostics are used to test a sample of tissue or
body fluids for microbial cultures or blood glucose. In-Vitro diagnostics functions include
testing changes in the liver function, imbalance in calcium levels in the body and electrolytes
in the blood such as sodium, urea, potassium and Creatinine
Global In-Vitro Diagnostics market is expected to witness growth owing to advancements in
the IVD technologies. Rising geriatric population base, growing prevalence of diabetes are the
key factors driving the growth of the market. Increasing Incidence of chronic diseases and
rapidly evolving healthcare environment due to growing awareness about various diseases
are expected to drive the In-Vitro market in the forecast period. Convergence of new
technologies and potential opportunities for outsourcing are the major opportunities for
future growth in the In-Vitro Diagnostics market
Global Market for In-Vitro Diagnostics is segmented on the basis of product, technology and
by application.
1) On the basis of product
Instruments,
Reagents and kits,
Data management system/software and services.
2) On the basis of technology
Clinical Chemistry,
Hematology,
Immunoassays,
Coagulation and Hemostasis,
Molecular diagnostics,
Microbiology and
Other IVD technologies.
3) On the basis of application
Diabetes,
Infectious Diseases,
Oncology/Cancer,
Cardiology,
Nephrology,
Autoimmune Diseases,
Drug testing and
+1 888-702-9626 | www.marketdataforecast.com | [email protected]